ArticleCureus2026
Assessment of Salivary Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels Among Subjects With Oral Squamous Cell Carcinoma, Periodontitis, Smokeless Tobacco Users, Smokers, and Healthy Individuals: A Cross-Sectional Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundNeutrophil gelatinase-associated lipocalin (NGAL) is an inflammatory biomarker implicated in periodontal tissue destruction and tumor progression. Tobacco use, both smoked and smokeless, is a key risk factor for periodontitis and oral squamous cell carcinoma (OSCC) and may influence NGAL expression. However, comparative evaluation of salivary NGAL levels across periodontal disease, tobacco users, and OSCC remains limited.
aimTo compare salivary NGAL levels among patients with OSCC, periodontitis, smoked tobacco users, smokeless tobacco (SLT) users, and healthy controls, and to assess the correlation of NGAL levels with periodontal clinical parameters. MATERIALS AND
methodsThis cross-sectional study included 125 participants divided into five groups (n = 25 each): OSCC, periodontitis, smokers, SLT users, and healthy controls. Periodontal parameters such as Oral Hygiene Index (OHI), Russell's Periodontal Index, probing pocket depth (PPD), and clinical attachment level (CAL) were recorded. Unstimulated whole saliva samples were collected and analyzed for NGAL levels using enzyme-linked immunosorbent assay (ELISA). Statistical analysis was performed using analysis of variance (ANOVA) with Tukey's post-hoc test and Pearson's correlation analysis (p < 0.05).
resultsSalivary NGAL levels showed a statistically significant difference among all groups (p < 0.001), with the highest levels observed in SLT users, followed by patients with OSCC, patients with periodontitis, smoked tobacco users, and healthy controls. Periodontal parameters were significantly worse in patients with periodontitis and SLT users, with no significant difference between these two groups. Salivary NGAL exhibited strong positive correlations with OHI, Russell's Index, PPD, and CAL (p < 0.001).
conclusionElevated salivary NGAL levels are significantly associated with periodontal disease severity, both smoked and SLT use, and OSCC. NGAL shows promise as a potential non-invasive biomarker for assessing inflammatory burden and disease risk in periodontal and tobacco-related oral conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.